Related Experiment Video

Updated: Jun 21, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review

Pavani Reddy1, Smitha Chadaga, Gary A Noskin

  • 1Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. p-reddy2@northwestern.edu

Journal of Hospital Medicine
|August 12, 2009
PubMed

Insights

Antimicrobial resistance is rising, with pathogens like MRSA and gram-negative bacteria becoming harder to treat. This review covers 8 new antibiotics for multidrug-resistant infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Rising antimicrobial resistance (AMR) in healthcare settings poses a significant public health threat.
  • Increasing rates of methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) gram-negative pathogens are observed.
  • Traditional antibiotic classes are becoming less effective against common hospital-acquired infections.

Observation:

  • Methicillin-resistant Staphylococcus aureus (MRSA) rates in ICUs have nearly doubled in the past decade.
  • Gram-negative bacteria like Pseudomonas aeruginosa, Acinetobacter baumannii, and ESBL-producing Enterobacteriaceae show escalating resistance.
  • Resistance extends to third-generation cephalosporins, fluoroquinolones, and carbapenems in some MDR strains.

Findings:

  • This review focuses on 8 antibiotics with emerging clinical utility.
  • These agents offer new treatment options for infections caused by MDR pathogens.
  • The case-based format aids in understanding practical applications.

Implications:

  • Hospitalists need to be aware of novel antibiotics for treating challenging infections.
  • Effective management of MDR pathogens is crucial to improve patient outcomes.
  • The emergence of new antibiotics is vital in combating the global AMR crisis.

More Related Videos

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antibiotic Selection00:57

Antibiotic Selection

Overview